Acorda began as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological diseases. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies for people with nervous system disorders. Collaboration remains an important part of our DNA. We continue to work with external academic and biopharmaceutical partners to advance the care of people affected by neurological diseases, and are interested in exploring new partnerships that combine compelling science with the potential to bring novel therapies to patients.

Acorda’s scientific, regulatory and commercial expertise, combined with an openness to creative collaboration structures, makes us an ideal partner for organizations that share our focus on neurology, innovation and commitment to improving the lives of patients.

For more information, please contact us at